Allergan, Inc.
Enhanced bimatoprost ophthalmic solution
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein.
Allergan, Inc.
A A A A A A A A A A A
A61K A61K A61P A61P A61K A61K A01N A61P A61K A61K A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Rhett M. Joan-En R. Scott James N. Chin-Ming
Schiffman Chang-Lin Jordan Chang Chang